NovoCure share price logo

NovoCure

NASDAQ: NVCR

Small Cap

$16.04

+0.04

(+0.28%)

Live

as on

NovoCure Stock Performance

as on October 1, 2026 at 3:07 am IST

  • Day's Low

    Day's High

    $15.73
    $16.07
    downward going graph

    1.93%

    Downside

    0.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.82
    $21.45
    downward going graph

    38.78%

    Downside

    33.73%

    Upside

    downward going graph

NovoCure share price movements today

Previous Close
$15.99
Open
$16.01
Volume
198.1K
Market Cap
$1.8B
Day's Low - High
$15.73 - $16.07
52 Week Low - High
$9.82 - $21.45

NovoCure Historical Returns

1 Month Return
-11.17 %
3 Month Return
+ 2.26 %
1 Year Return
+ 22.52 %
3 Year Return
-1.98 %
5 Year Return
-86.37 %

NovoCure Stock Fundamentals & Key Indicators

Check NovoCure market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-1.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.06%

PE Ratio (TTM)

-12.18

Industry PE ratio

-7.34

PEG Ratio

-3.84

EBITDA

-134.4M

Revenue (TTM)

699.2M

Profit Margin

76.13%

Return On Equity TTM

-44.00%

NovoCure vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NovoCure with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NovoCure image
NovoCure
Neutral$1.8B-86.37%-12.1876.13%0.00%
Edwards Lifesciences image
Edwards Lifesciences
Buy$50.0B-22.20%49.9077.98%0.00%
Medtronic image
Medtronic
Buy$113.4B-30.52%21.8866.69%3.20%
Abbott Laboratories image
Abbott Laboratories
StrongBuy$175.3B-14.54%32.4756.80%2.46%
Stryker image
Stryker
StrongBuy$104.5B5.71%28.2965.17%1.26%
See all

Stock Returns calculator for NovoCure Stock including INR - Dollar returns

The NovoCure stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

NovoCure investment value today

Current value as on today

₹1,33,915

Returns

₹33,915

(+33.92%)

Returns from NovoCure Stock

₹24,149 (+24.15%)

Dollar Impact

₹9,767 (+9.77%)

Analyst Recommendation on NovoCure Stock

Based on 2 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'HOLD' rating for NovoCure. Average target price of $27.14

NovoCure Share Price Target

Get share price movements and forecasts by analysts on NovoCure.

What analysts predicted

40.9%UPSIDE

Target Price

$27.14

Current Price

$16.04

Analyzed by

2 Analysts

High

$20

Target

$27.14

Low

$17

NovoCure target price $27.14, a slight upside of 40.9% compared to current price of $16.04. According to 2 analysts rating.

Indian Investors' Interest in NovoCure Stock

Search interest for NovoCure Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-24% versus previous 30 day period

NovoCure Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
138
150
155
161
154
158
167
174
174
183
Gross Profit
104
115
119
127
116
117
122
132
135
142
Operating Income
-41
-33
-32
-63
-37
-39
-36
-40
-67
-10
EBITDA
-28
-19
-19
-10
-26
-31
-26
-34
-63
-10
Interest Expense
-
-
-
-
-
-
-
0
1
-
Depreciation
2
2
2
3
3
3
3
6
4
-
Income Before Tax
-31
-22
-21
-55
-30
-34
-30
-40
-69
-12
Income Tax Expense
7
10
8
10
4
5
7
-16
1
3
Net Income
-38
-33
-30
-65
-34
-40
-37
-24
-71
-15
Net Profit Margin
75.68%
76.95%
77.19%
79.25%
75.15%
73.88%
73.25%
75.82%
77.63%
77.61%

NovoCure Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
177
248
351
494
535
537
509
605
655
Gross Profit
121
168
262
387
420
422
381
468
488
Operating Income
-39
-33
0
30
-44
-89
-232
-170
-153
EBITDA
-29
-23
13
44
-38
-67
-177
-109
-119
Interest Expense
11
16
14
18
8
8
4
11
-
Depreciation
7
9
8
9
10
10
10
11
17
Income Before Tax
-48
-45
-8
18
-52
-81
-191
-131
-136
Income Tax Expense
13
17
-1
-1
6
10
15
37
0
Net Income
-61
-63
-7
19
-58
-92
-207
-168
-136
Net Profit Margin
68.59%
67.73%
74.78%
78.46%
78.53%
78.64%
74.81%
77.33%
74.54%

NovoCure Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-38
-33
-30
-65
-34
-40
-37
-24
-71
-15
Operating Cash Flow
-31
-1
10
-3
-35
-15
20
-18
-13
12
Investing Cash Flow
246
-374
10
-22
-6
35
71
336
7
-6
Financing Cash Flow
0
87
0
2
5
2
100
-559
0
4
Change in Cash
214
-288
20
-23
-36
22
192
-241
-6
10

NovoCure Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-61
-63
-7
19
-58
-92
-207
-168
-136
Operating Cash Flow
-33
-1
26
99
82
30
-73
-26
-49
Investing Cash Flow
6
-5
-51
-472
-144
-139
184
-140
437
Financing Cash Flow
5
69
61
440
25
15
15
90
-451
Change in Cash
-21
62
36
66
-36
-93
126
-76
-62

Global Institutional Holdings in NovoCure

Check out the Institutions with significant holdings in NovoCure.

Funds
Holdings
Vanguard
8.40%
Fidelity Mt. Vernon Street Trust
7.51%
VANGUARD INDEX FUNDS
7.20%
iShares
5.12%
BlackRock Funds
1.08%
See all

NovoCure News & Key Events

  • img

    Today's Timeline - 01 September

    Tue, 05:24 PM

    -

    Novocure reports cyberattack exposed records of over 1,400 U.S. patients but expects no material financial impact.

Insights on NovoCure

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NVCR has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, NVCR stock has moved up by 54.3%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 174.05M → 183.58M (in $), with an average increase of 5.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -71.13M → -15.65M (in $), with an average increase of 354.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 27.1% return, outperforming this stock by 28.1%

About NovoCure

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
OrganisationNovoCure
HeadquartersNeuhofstrasse 21, Baar, 6340, CH
IndustryMedical - Devices
CEOFrank Leonard

Key Management of NovoCure

Name

Title

Mr. William F. Doyle

Executive Chairman

Mr. Frank Leonard

CEO & Director

Mr. Christoph Brackmann

Chief Financial Officer

Mr. Michael Puri

Chief Human Resources Officer

Dr. Uri Weinberg M.D., Ph.D.

Chief Innovation Officer & Chief Medical Officer

Mr. Mukund Paravasthu

Chief Operating Officer

Mr. Adam Daney

Head of Investor Relations

Mr. Barak Ben-Arye

General Counsel

FAQs

What is NovoCure share price today?

NovoCure share price today is $16.04 as on . NovoCure share today touched a day high of $16.07 and a low of $15.73.

What is the 52 week high and 52 week low for NovoCure share?

NovoCure share touched a 52 week high of $21.45 on and a 52 week low of $9.82 on . NovoCure stock price today i.e. is trending at $16.04,which is 25.22% down from its 52 week high and 63.34% up from its 52 week low.

What is NovoCure's market capitalisation today?

NovoCure market capitalisation is $0.00T as on .

How to invest in NovoCure Stock (NVCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NovoCure on INDmoney app. Click on Buy button.

What is the minimum amount required to buy NovoCure Stock (NVCR) from India?

Indian investors can start investing in NovoCure (NVCR) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in NovoCure stock (as per the Rupee-Dollar exchange rate as on ). Based on NovoCure share’s latest price of $16.04 as on September 30, 2026 at 9:37 pm IST, you will get 0.6234 shares of NovoCure. Learn more about fractional shares .

What are the returns that NovoCure has given to Indian investors in the last 5 years?

NovoCure stock has given -86.37% share price returns and 29.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?